NCT03581539

Brief Summary

All three methods of postoperative analgesia have been shown to decrease postoperative pain control in nephrectomy patients, the three methods have never been compared to each other. This study aims to compare three different pain techniques proven to be beneficial in surgical nephrectomies, including the efficacy and the side effects of each technique.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
120

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started May 2018

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

May 22, 2018

Completed
22 days until next milestone

First Submitted

Initial submission to the registry

June 13, 2018

Completed
27 days until next milestone

First Posted

Study publicly available on registry

July 10, 2018

Completed
2.4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 17, 2020

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

November 17, 2020

Completed
Last Updated

June 27, 2023

Status Verified

June 1, 2023

Enrollment Period

2.5 years

First QC Date

June 13, 2018

Last Update Submit

June 26, 2023

Conditions

Keywords

Laparoscopic Nephrectomy,Simple NephrectomyPartial NephrectomyPain,acutePain,postoperative

Outcome Measures

Primary Outcomes (2)

  • Primary endpoint of this study will be VAS pain score at 24 hours

    The VAS scores will be taken with both rest and movement (knee flexion) and will be measured by a study team investigator using Visual Analog Scale (VAS). Using a scale of 1-10 for documentation with 10 being the worst pain and 0 being no pain

    Pain scores will be measured 24 hours after surgery

  • Primary endpoint of this study will be VAS pain score at 48 hours

    Pain scores will be measured by a study team investigator using Visual Analog Scale (VAS). Using a scale of 1-10 for documentation with 10 being the worst pain and 0 being no pain

    Pain scores will be measured 48 hours after surgery

Secondary Outcomes (1)

  • Secondary endpoint includes total IV and PO (By Mouth) opioid consumption at 72 hours

    Opioid consumption will be measured at 1 hour post op, 24, 48, and 72 hours post op. The total amount will be recorded

Other Outcomes (4)

  • Average Nausea scores over 72 hours

    Nausea scores will be documented at 1 hour post op, 24, 48, and 72 hours after the block. The scores will then be averaged

  • Average Sedation scores over 72 hours

    Sedation scores will be documented at 1 hour post op, 24, 48, and 72 hours after the block. The scores will then be averaged

  • Subjects overall satisfaction scores

    Post operatively at hour 24

  • +1 more other outcomes

Study Arms (3)

Group #1

ACTIVE COMPARATOR

Transverses Abdominis Plane (TAP) block

Procedure: Transverses Abdominis Plane (TAP) block

Group #2

ACTIVE COMPARATOR

Quadratus Lumborum (QL) block

Procedure: Quadratus Lumborum (QL) block

Group #3

ACTIVE COMPARATOR

Surgeon Infiltration using Exparel

Procedure: Surgeon Infiltration using Exparel

Interventions

TAP block - Participants will get an injection of bupivacaine and exparel (numbing medicine) in the four different locations of your stomach. To be more specific, the injection placed between your oblique muscles in four different locations right after you are asleep and just before the start of surgery. Investigators will use an ultrasound machine (the machine works by taking pictures of internal organs by bouncing sound waves off them and recording the echoes) to find the abdominal muscle layers and find the correct location to inject the numbing medicine between the muscle layers.

Group #1

QL block - Participants will get an injection of bupivacaine with exparel (numbing medicine) in two locations in your lower stomach. To be more specific, an injection will take place inside your quadratus lumborum muscle which is slightly deeper than your oblique muscles right after you are asleep and right before surgery. Investigators will use an ultrasound machine (the machine works by taking pictures of internal organs by bouncing sound waves off them and recording the echoes) to find the abdominal muscle layers and find the correct location to inject the numbing medicine between the muscle layers.

Group #2

SI group - at the end of the surgery and just prior to you waking up, the surgeon will use a needle to inject the surgical incision site with bupivacaine and exparel (numbing medicine) spreading the medicine evenly as the needle is slowly withdrawn to make sure all layers are evenly filled with the medicine that will numb the area.

Group #3

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patients undergoing laparoscopic nephrectomy including partial, simple and radical nephrectomy
  • ASA class 1, 2, 3 or 4
  • Age 18 or older, male or female

You may not qualify if:

  • Any contraindication for TAP block, QL block or surgeon infiltration
  • Donor Nephrectomy
  • History of substance abuse in the past 6 months
  • Patients on more than 30mg po morphine equivalents of opioids, staff anesthesiologist will confirm this portion prior to enrollment.
  • Any physical, mental or medical conditions which in the opinion of the investigators, may confound quantifying postoperative pain resulting from surgery.
  • Known allergy to bupivacaine or Exparel
  • Patients \<40kg or \>110 kg TBW

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Indiana University Hospital

Indianapolis, Indiana, 46202, United States

Location

MeSH Terms

Conditions

Acute PainPain, Postoperative

Interventions

Dental Occlusion

Condition Hierarchy (Ancestors)

PainNeurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and SymptomsPostoperative ComplicationsPathologic Processes

Intervention Hierarchy (Ancestors)

DentistryDental Physiological PhenomenaDigestive System and Oral Physiological Phenomena

Study Officials

  • Kevin M Backfish-White, MD

    Indiana University School of Medicine

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: Patients randomized to four-quadrant Transverses Abdominis Plane (TAP) block, Quadratus Lumborum (QL) block or surgeon infiltration using Exparel for postoperative analgesia after laparoscopic nephrectomy
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Anesthesiologist

Study Record Dates

First Submitted

June 13, 2018

First Posted

July 10, 2018

Study Start

May 22, 2018

Primary Completion

November 17, 2020

Study Completion

November 17, 2020

Last Updated

June 27, 2023

Record last verified: 2023-06

Locations